Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001931356-26-000009·Angel Matthew
Schedule 13D ownership disclosure
TEMPEST THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 87978U207
Event date: 2026-02-03
- Filing-level shares
- 4,837,070.00
- Percent of class
- 35.9%
- Matthew AngelReported CIK 0001931356
Shares: 4,837,070.00 · Class: 35.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001931356-26-000009
- Form type
- SCHEDULE 13D
- Filer
- Angel Matthew
- CIK
- CIK 1931356
- Filed
- Feb 10, 2026
- Reporting period
- Feb 03, 2026
- Description
- Schedule 13D beneficial ownership